Sarah M Risard Selected Research

Hemorrhage

6/2011	Intravitreal ranibizumab for macular edema secondary to central retinal vein occlusion.
1/2009	Retinal neovascularization associated with a retinal arterial macroaneurysm.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sarah M Risard Research Topics

Disease

2	Macular Edema 06/2011 - 01/2009
2	Edema (Dropsy) 06/2011 - 01/2009
2	Hemorrhage 06/2011 - 01/2009
1	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2011
1	Retinal Vein Occlusion 06/2011
1	Aneurysm (Aneurysms) 01/2009
1	Melanoma (Melanoma, Malignant) 01/2009

Drug/Important Bio-Agent (IBA)

2	Fluorescein (Funduscein)FDA LinkGeneric 06/2011 - 01/2009
2	Retinaldehyde (Retinal)IBA 06/2011 - 01/2009
1	Ranibizumab (Lucentis)FDA Link 06/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2009
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2009
1	Albumin-Bound Paclitaxel FDA Link 01/2009
1	LipidsIBA 01/2009
1	SteroidsIBA 01/2009

Therapy/Procedure

1	Aftercare (After-Treatment) 06/2011
1	Injections 06/2011
1	Lasers (Laser) 01/2009
1	Drug Therapy (Chemotherapy) 01/2009
1	Light Coagulation 01/2009
1	Therapeutics 01/2009